David prepares and prosecutes patent applications for technologies in the life sciences sector. Prior to joining J A Kemp, David worked as a patent agent at a private practice law firm in the United States and has extensive experience with US patent practice.
David has over a decade of research experience in the fields of protein biochemistry, immunology and molecular biology. He has held research positions at the Scripps Research Institute in California, and at the US Centers for Disease Control and Prevention (CDC) in Georgia.
David’s graduate and post-graduate research focussed on structure-based design of anti-viral therapeutics and development of vaccines. He has co-authored numerous research articles and text books, and is named as a co-inventor on multiple patents and pending applications.
David is particularly experienced in preparation and prosecution of patent applications for early stage innovations. He has leveraged his research experience to patent technologies relating to antibodies and vaccines, medical devices, biological nanotechnologies, anaesthetics and anticancer therapies.
David’s experience with US practice enables him to advise clients about substantive and procedural differences between European and US patent practice, and prosecute applications with a view to coordinating protection in Europe and the USA. He is experienced with corresponding global patent filings, and has participated in oral proceedings at the United States Patent Trials and Appeals Board, attended opposition proceedings at the European Patent Office and assisted invalidation trial proceedings in Japan.
David joined J A Kemp as an associate in 2018.
University College, London, Bachelor’s degree in Medical Microbiology; University of Oxford, DPhil in Biochemistry
US Patent Agent
Student member of the Chartered Institute of Patent Attorneys (CIPA)